Table 1.

Baseline characteristics for 28 LPL patients enrolled in the study

	Median	Range
Age, y	59.5	33-75
Male/female	18/10	N/A
Previously treated, n (%)	23 (82.1)	N/A
Median prior therapies, n	2	0-5
Bone marrow involvement, %	30	5-90
Adenopathy/splenomegaly, n (%)	5 (17.9)	N/A
Serum IgM, mg/dL	3510	622-12 000
B2M, mg/L	3.1	1.3-6.9
Hematocrit, %	35.0	24.4-42.8
Platelets, 1000/μL	232	72-486
Leukocytes, 1000/μL	5.45	2-13

B₂M indicates beta 2 microglobulin; and N/A, not applicable.